Apyx Medical Corp (APYX) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Apyx Medical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Apyx Medical Corp Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$7.58 M, a 118% decline year-over-year.
  • Apyx Medical Corp Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$22.8 M, a 10.1% decline year-over-year.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$18.7 M, a 19.3% increase from 2022.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$23.2 M, a 52.8% decline from 2021.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$15.2 M, a 27.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$22.8 M -$7.58 M -$4.09 M -118% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$18.7 M -$9.61 M -$3.56 M -58.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$15.2 M -$4.63 M +$1.14 M +19.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$16.3 M -$994 K +$4.43 M +81.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$20.7 M -$3.48 M +$2.46 M +41.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$23.2 M -$6.05 M -$4.05 M -202% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$19.1 M -$5.76 M -$1.54 M -36.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$17.6 M -$5.43 M -$1.38 M -34.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$16.2 M -$5.95 M -$1.04 M -21.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$15.2 M -$2 M -$476 K -31.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$14.7 M -$4.22 M -$494 K -13.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$14.2 M -$4.05 M +$644 K +13.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$14.8 M -$4.9 M -$2.95 M -151% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$11.9 M -$1.53 M +$3.86 M +71.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$15.8 M -$3.73 M +$642 K +14.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$16.4 M -$4.69 M -$352 K -8.11% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$16 M -$1.95 M +$3.66 M +65.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$19.7 M -$5.39 M -$3.51 M -187% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16.2 M -$4.37 M -$72.8 M -106% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $56.6 M -$4.34 M -$1.4 M -47.7% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $58 M -$5.61 M -$4.67 M -500% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-08
Q4 2018 $62.7 M -$1.88 M -$1.05 M -128% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 $63.8 M $68.5 M +$69.7 M Jul 1, 2018 Sep 30, 2018 10-Q/A 2020-05-08
Q2 2018 -$5.94 M -$2.94 M -$1.63 M -125% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$4.31 M -$935 K +$750 K +44.5% Jan 1, 2018 Mar 31, 2018 10-Q/A 2020-05-08
Q4 2017 -$5.06 M -$824 K +$7.3 M +89.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-31
Q3 2017 -$12.4 M -$1.25 M -$280 K -29% Jul 1, 2017 Sep 30, 2017 10-Q/A 2020-05-08
Q2 2017 -$12.1 M -$1.31 M -$789 K -152% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$11.3 M -$1.69 M +$259 K +13.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$11.6 M -$8.12 M -$6.71 M -476% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$4.84 M -$965 K +$622 K +39.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$5.46 M -$519 K +$978 K +65.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$6.44 M -$1.94 M -$1.07 M -122% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$5.37 M -$1.41 M +$4.04 M +74.1% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-18
Q3 2015 -$9.41 M -$1.59 M +$1.39 M +46.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 -$10.8 M -$1.5 M -$1.53 M -5262% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$9.28 M -$876 K +$8.94 M +91.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$18.2 M -$5.45 M -$329 K -6.42% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$17.9 M -$2.98 M -$2.64 M -773% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$15.2 M $29 K +$1.15 M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$16.4 M -$9.81 M -$9.4 M -2299% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
Q4 2013 -$6.99 M -$5.13 M -$5.41 M -1898% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$1.58 M -$341 K -$334 K -4771% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 -$1.25 M -$1.12 M -$1.27 M -836% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 $21 K -$409 K -$596 K -319% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 $617 K $285 K +$1.16 M Oct 1, 2012 Dec 31, 2012 10-K/A 2014-05-08
Q3 2012 -$543 K -$7 K -$70 K -111% Jul 1, 2012 Sep 30, 2012 10-K/A 2014-05-08
Q2 2012 -$473 K $152 K -$277 K -64.6% Apr 1, 2012 Jun 30, 2012 10-K/A 2014-05-08
Q1 2012 -$196 K $187 K -$305 K -62% Jan 1, 2012 Mar 31, 2012 10-K/A 2014-05-08
Q4 2011 $109 K -$875 K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 $63 K +$59 K +1475% Jul 1, 2011 Sep 30, 2011 10-K 2013-04-01
Q2 2011 $429 K +$373 K +666% Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 $492 K Jan 1, 2011 Mar 31, 2011 10-K 2013-04-01
Q3 2010 $4 K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $56 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.